Milestone Pharmaceuticals...
1.97
0.01 (0.51%)
At close: Jan 15, 2025, 3:59 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -59.69M -58.39M -42.85M -49.97M -55.23M -23.18M -8.09M
Depreciation & Amortization 92.00K 89.00K 93.00K 97.00K 38.00K 10.00K 8.00K
Stock-Based Compensation 9.53M 9.05M 7.28M 4.95M 1.19M 633.00K 190.00K
Other Working Capital 1.24M -2.35M 1.62M -3.72M -672.00K -1.38M 58.00K
Other Non-Cash Items 2.39M 44.00K 7.27M 5.53M 1.63M 787.00K 59.00K
Deferred Income Tax n/a n/a -7.27M -5.53M -1.63M n/a n/a
Change in Working Capital 1.24M -3.26M 2.26M -5.81M 2.85M 1.50M -164.00K
Operating Cash Flow -46.42M -52.47M -33.22M -50.73M -51.15M -21.05M -8.05M
Capital Expenditures -112.00K -272.00K n/a n/a -413.00K -5.00K -36.00K
Acquisitions n/a 86.12M n/a n/a 35.41M n/a n/a
Purchase of Investments -137.13M -85.85M -15.00M -90.00M -35.00M -3.03M -16.03M
Sales Maturities Of Investments 142.00M 29.00M 85.00M 20.00M 35.03M 19.03M 45.00K
Other Investing Acitivies n/a -86.12M 70.00M -70.00M -35.41M 16.00M -15.99M
Investing Cash Flow 4.76M -57.12M 70.00M -70.00M -384.00K 16.00M -16.02M
Debt Repayment 50.00M n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -2.21M 458.00K 5.05M 48.31M 44.00K 80.11M 30.72M
Financial Cash Flow 47.79M 3.09M 5.05M 73.22M 85.41M 80.11M 30.72M
Net Cash Flow 6.12M -106.50M 41.83M -47.51M 33.87M 75.07M 6.65M
Free Cash Flow -46.54M -52.74M -33.22M -50.73M -51.56M -21.05M -8.09M

Create Price Alert on MIST

Your price alert will notify you when the stock price is above 1.97.

Add to Watchlist